Mahmud Hasan
Postdoctoral Fellow, Radiology Department, Johns Hopkins University School of Medicine
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.
Dodda, B. R., Bondi, C. D., Hasan, M., Clafshenkel, W. P., Gallagher, K. M., Kotlarczyk, M. P., Sethi, S., Buszko, E., Latimer, J. J., Cline, J. M., Witt-Enderby, P. A., & Davis, V. L. (2019). Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer. Frontiers in oncology, 9, 525. https://doi.org/10.3389/fonc.2019.00525.
Description
Dodda, B. R., Bondi, C. D., Hasan, M., Clafshenkel, W. P., Gallagher, K. M., Kotlarczyk, M. P., Sethi, S., Buszko, E., Latimer, J. J., Cline, J. M., Witt-Enderby, P. A., & Davis, V. L. (2019).
Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.